Osteosarcoma: A Surveillance, Epidemiology, and End Results program‐based analysis from 1975 to 2017
National Institutes of Health · Walter Reed National Military Medical Center · +2 more institutions
Abstract
Osteosarcoma is the most common primary bone malignancy. As a rare cancer, population-based studies remain small with limited information on finer demographic categories. Recent studies have reported important genetic differences based on age and ethnicity, and more detailed studies are needed to better understand potentially important osteosarcoma risk groups.
Incidence and survival rates for 5016 patients with osteosarcoma from the Surveillance, Epidemiology, and End Results (SEER) program (1975-2017) were analyzed by age (0-9, 10-24, 25-59, and >60 years old), race/ethnicity, histologic subtype, stage, and tumor location using SEER*Stat software.
Citation impact
- FWCI
- 34.90
- Percentile
- 100%
- References
- 41
Authors
4- SCSarah Cole
National Institutes of Health, Walter Reed National Military Medical Center, National Cancer Institute, Department of Health and Human Services
- DMD. Matthew Gianferante
National Institutes of Health, National Cancer Institute, Department of Health and Human Services
- BZBin Zhu
National Institutes of Health, National Cancer Institute, Department of Health and Human Services
- LMLisa MirabelloCorresponding
National Institutes of Health, National Cancer Institute, Department of Health and Human Services
Topics & keywords
- Osteosarcoma
- Medicine
- Incidence (geometry)
- Epidemiology
- Surveillance, Epidemiology, and End Results
- Population
- Ethnic group
- Demography
- Good health and well-being